Clinical Study

Renal Transplantation Dramatically Reduces IgA Anti-beta-2-glycoprotein I Antibodies in Patients with Endstage Renal Disease

Figure 5

IgA aB2GPI antibodies in posttransplant serum samples grouped in time periods after transplant. (a) Mean levels of antibodies (U/mL) compared with pretransplant samples. The first trimester (period of less levels) compared with the other periods. (b) Percentage of sera positive for IgA aB2GP compared with pretransplant. The first trimester period of lower levels is also compared with the other periods. Tx: transplant.
641962.fig.005a
(a)
641962.fig.005b
(b)